
Pro-inflammatory cervicovaginal bacteria increased HIV risk more than 4-fold in women.

Pro-inflammatory cervicovaginal bacteria increased HIV risk more than 4-fold in women.

African American women account for 62% of women diagnosed with HIV.

Top articles of the week from Specialty Pharmacy Times.

Prevention programs, HIV testing, and easier access to treatment are all areas that need to be addressed.

Would federal funding cuts to the Ryan White Care Act be "devastating" to the HIV-positive population?

Gene may induce a broad-spectrum cellular response against infectious diseases.

Top news of the day from across the health care landscape.

Streptococcus pneumonia is an indiscriminate killer.

Scarlet fever, also known as scarlatina, is a bacterial infection caused by group A Streptococcus or “group A strep.”

Mumps is a highly contagious disease caused by a virus that spreads through direct contact with respiratory secretions.

Most of the Ebola-related deaths in West Africa could have been prevented, experts say.

The new test service helps physicians assess patient’s responses to antiretroviral therapy for HBV.

Antibody well tolerated in patients with HIV.

The majority of HIV-positive individuals 50 years or older live on or below the poverty line.

Top news of the day from across the health care landscape.

Antiretrovirals may increase vulnerability to syphilis in males with HIV.

Top news of the day from across the health care landscape.

South African Pharmacy Council lifts ban preventing pharmacies from selling DIY HIV test kits.

Beneficial effects seen in blocking the immune response against HIV.

Company seeks to leverage technologies to address unmet needs.

Scientists solve structural details of HIV machinery.

Cancer accounts for more years of life lost than any other cause of death.

Vaccine-preventable disease death rates have decreased since 1980.

Scedosporium is a fungal pathogen that is resistant against most antifungals.

Officials with the FDA have rejected new drug applications for Cempra's community-acquired bacterial pneumonia (CABP) antibiotic, according to a press release from Cempra.